“…Increasing evidence has also supported the possibility that L. casei strain Shirota can act as an effective immunomodulator in humans. Oral administration of L. casei strain Shirota restored NK cell activity in subjects with relatively low NK cell activity (20,24,25), although it remains to be investigated whether L. casei strain Shirota-mediated recovery of NK cell activity was connected with a reduction in cancer incidence (2,12,27). Previous studies using experimental murine models showed that L. casei strain Shirota could prevent infections of pathogenic bacteria and viruses through the activation of innate immune defenses (10,22) and inhibit the development of allergies, autoimmune diseases, and inflammatory bowel diseases, probably through normalizing dysregulated host immune systems (16,19,21,23,34).…”